Canaan X L.P.

Canaan X L.P. is a declared insider at 5 companies; the most frequent names are Protagonist Therapeutics, Inc, NextCure, Inc. and Iterum Therapeutics plc. We count 26 filings; the first trade dates from 13 March 2018 and the latest from 31 December 2021.

On the open market, the record shows 3 purchases worth €9.9M and 13 sales worth €3.3M. Netting one side against the other leaves €6.6M of net buying. Unlike grants, an open-market purchase is paid for by the insider, at the market price.

A typical purchase (the median) is worth €3.6M.

On 4 January 2022 came the latest disclosure, a transaction in Astra Space, Inc. The last purchase on record was published on 28 May 2019, which is 2,705 days ago. Publication is fast: at least half of the trades appear on SEC (Form 4) on the same day. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.